Inicio › Tumores cerebrales › California › Los Angeles
Ensayos clínicos de Tumores cerebrales en Los Angeles, CA
16 estudios para Tumores cerebrales buscan participantes en centros de Los Angeles y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
ReclutandoFase 2
- Cedars-Sinai Medical Center, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
ReclutandoFase 1/2
- University of Southern California, Los Angeles
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
ReclutandoFase 1/2
- Cedars-Sinai Medical Center, Los Angeles
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
ReclutandoFase 1/2
- The Angeles clinic - A cedars SINAI AFFILIATE, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
ReclutandoFase 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Phase 1/1b Study of IAM1363 in HER2 Cancers
ReclutandoFase 1
- USC Norris Comprehensive Cancer Center, Los Angeles
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
ReclutandoFase 1/2
- California Research Institute, Los Angeles
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
ReclutandoFase 2
- Univ. of California Los Angeles, Los Angeles
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
ReclutandoFase 2
- Children's Hospital Los Angeles, Los Angeles
REMASTer: REcurrent Brain Metastases After SRS Trial
Reclutando
- UCLA, Los Angeles
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
ReclutandoFase 1/2
- University of California Los Angeles, Los Angeles
CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children
ReclutandoFase 1
- Children's Hospital Los Angeles, Los Angeles
Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
ReclutandoFase 1
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
Reclutando
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
ReclutandoFase 3
- USC / Norris Comprehensive Cancer Center, Los Angeles
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
ReclutandoFase 2
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Más información sobre Tumores cerebrales en MedlinePlus
Ensayos de Tumores cerebrales en otras ciudades
- Houston, TX35 estudios
- Boston, MA28 estudios
- New York City, NY25 estudios
- Washington, DC20 estudios
- Miami, FL15 estudios
- Durham, NC14 estudios
- St. Louis, MO12 estudios
- Rochester, MN11 estudios
- Chicago, IL11 estudios
- Cleveland, OH11 estudios
- Baltimore, MD11 estudios
- Seattle, WA11 estudios
Otros estudios en Los Angeles
- Cáncer de pulmón de células no pequeñas87 estudios
- Cáncer (todos los tipos)74 estudios
- Cáncer de seno73 estudios
- Cáncer de próstata61 estudios
- Cáncer del colon y del recto59 estudios
- Cáncer metastásico57 estudios
- Cáncer de ovario50 estudios
- Cáncer de pulmón45 estudios
- Carcinoma de células escamosas de cabeza y cuello42 estudios
- Cáncer de páncreas35 estudios
- Cáncer de endometrio34 estudios
- Melanoma34 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.